ABBOTT PARK, Ill., April 28, 2010 - Abbott announced today that the U.S. Food and Drug Administration (FDA) approved once-daily dosing of Kaletra(R) (lopinavir/ritonavir) for adult patients with HIV who have previously taken antiretroviral therapy. Kaletra once-daily dosing is already indicated for adult patients new to antiretroviral treatment. This gives treatment-experienced patients who have HIV that [...]